Complement levels at admission as a reflection of coronavirus disease 2019 (COVID‐19) severity state
Open Access
- 11 May 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (9) , 5515-5522
Abstract
Complement system hyperactivation has been proposed as a potential driver of adverse outcomes in severe acute respiratory syndrome coronavirus 2 infected patients, given prior research of complement deposits found in tissue and blood samples, as well as evidence of clinical improvement with anticomplement therapy. Its role in augmenting thrombotic microangiopathy mediated organ damage has also been implicated in coronavirus disease 2019 (COVID‐19). This study aimed to examine associations between complement parameters and progression to severe COVID‐19 illness, as well as correlations with other systems. Blood samples of COVID‐19 patients presenting to the emergency department (ED) were analyzed for a wide panel of complement and inflammatory biomarkers. The primary outcome was COVID‐19 severity at index ED visit, while the secondary outcome was peak disease severity over the course of illness. Fifty‐two COVID‐19 patients were enrolled. C3a (p = 0.018), C3a/C3 ratio (p = 0.002), and sC5b‐9/C3 ratio (p = 0.021) were significantly elevated in with severe disease at ED presentation. Over the course of illness, C3a (p = 0.028) and C3a/C3 ratio (p = 0.003) were highest in the moderate severity group. In multivariate regression controlled for confounders, complement hyperactivation failed to predict progression to severe disease. C3a, C3a/C3 ratio, and sC5b‐9/C3 ratio were correlated positively with numerous inflammatory biomarkers, fibrinogen, and VWF:Ag, and negatively with plasminogen and ADAMTS13 activity. We found evidence of complement hyperactivation in COVID‐19, associated with hyperinflammation and thrombotic microangiopathy. Complement inhibition should be further investigated for potential benefit in patients displaying a hyperinflammatory and microangiopathic phenotype.Keywords
This publication has 29 references indexed in Scilit:
- Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitisClinical Rheumatology, 2019
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus PathogenesismBio, 2018
- Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and ThrombosisCirculation, 2018
- Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathiesImmunobiology, 2017
- Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pHFrontiers in Immunology, 2015
- Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the MythThe Journal of Immunology, 2015
- Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic MicroangiopathyThe Journal of Immunology, 2013
- The complement systemCell and tissue research, 2010
- Complement and its role in innate and adaptive immune responsesCell Research, 2009
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009